Fmr LLC Increases Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Fmr LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,840,892 shares of the biopharmaceutical company’s stock after buying an additional 669,517 shares during the period. Regeneron Pharmaceuticals accounts […]

Related Keywords

Canada ,Bonniel Bassler ,Arthurf Ryan ,Raymond James ,Regeneron Pharmaceuticals Inc ,Regeneron Pharmaceuticals Stock Down ,Milestone Investment Advisors ,Securities Exchange Commission ,Annis Gardner Whiting Capital Advisors ,Insider Transactions At Regeneron Pharmaceuticals ,Jefferies Financial Group ,News Ratings For Regeneron Pharmaceuticals Daily ,Regeneron Pharmaceuticals Profile ,Sunbelt Securities Inc ,Nasdaq ,Cantor Fitzgerald ,Regeneron Pharmaceuticals ,Sutton Wealth Advisors Inc ,Royal Bank ,Quarter For Regeneron Pharmaceuticals ,Benjaminf Edwards Company Inc ,Free Report ,Gardner Whiting Capital Advisors ,Wealth Advisors ,Pharmaceuticals Stock Down ,Get Free Report ,Director Arthur ,Director Bonnie ,Exchange Commission ,Financial Group ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,Nasdaq Regn ,Regn ,Medical ,75886f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,